Makes infection prevention products for healthcare providers.
Jun 2026Revenue $6.04B/yrExpenses $4.90B/yr
No trend
Figures by year
Is STERIS profitable?
Yes. In the 12 months to Jun 2026, revenue was $6.04B and expenses $4.90B.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Mar 2026 | $5.94B | $4.83B | $1.10B |
| Mar 2025 | $5.46B | $4.59B | $867M |
| Mar 2024 | $5.14B | $4.30B | $836M |
| Mar 2023 | $4.54B | $3.75B | $791M |
| Mar 2022 | $4.22B | $3.75B | $478M |
| Mar 2021 | $3.11B | $2.56B | $548M |
| Mar 2020 | $3.03B | $2.49B | $537M |
| Mar 2019 | $2.78B | $2.37B | $411M |
| Mar 2018 | $2.62B | $2.22B | $400M |
| Mar 2017 | $2.61B | $2.39B | $226M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.